The Global Coalition for Adaptive Research (GCAR) announced today that the GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment) clinical trial is opening its first clinical site, the Henry Ford Cancer Institute, and will begin enrolling patients this week. GBM AGILE is the world’s first global adaptive clinical trial platform…...
News digest – NHS staff shortages, HPV vaccine in Rwanda, prostate cancer guidelines and sunscreen chemicals
Read about this week News Digest’s cancer research breakthrough headlines including National screening programs, a new drug for aggressive childhood brain cancer, HPV vaccination in Rwanda, and more. Original article at: https://scienceblog.cancerresearchuk.org/2019/05/11/news-digest-nhs-staff-shortages-hpv-vaccine-in-rwanda-prostate-cancer-guidelines-and-sunscreen-chemicals/...
Skin and breast cancer drugs approved for NHS use in Scotland
Two cancer drugs have been approved for patients on the NHS in Scotland. An immunotherapy for some people with advanced skin cancer and a targeted drug for some patients with breast cancer got the green light this week. Pembrolizumab (Keytruda) will now be an option for patients whose melanoma has spread to the…...
Bowel cancer rates are rising in young adults, but do we know what’s behind the increase?
Bowel cancer rates are increasing in adults aged between 20 and 50, according to data from 2 big studies published this week. Both studies looked at large numbers of people across several countries, including the UK, providing strong evidence on the number of people developing bowel cancer. And some worrying trends emerged.…...
News digest – bowel cancer rates, brain tumour ‘pink drink’, cigarette displays and chewing gum
Grace Li New from News Digest this week: follow with new breakthroughs and research on bowel cancer rates, brain tumor “pink drink”, cigarette displays and chewing gum. Read more at: https://scienceblog.cancerresearchuk.org/2019/05/18/news-digest-bowel-cancer-rates-brain-tumour-pink-drink-cigarette-displays-and-chewing-gum/...
AFCR Scientific Advisory Board Chairman’s Brain Cancer Efforts Recognized
W.K. Alfred Yung, M.D., a brain cancer researcher and chairman of the Asian Fund for Cancer Research’s scientific advisory board, was last week presented with the 3rd Annual SNOChina Award for Outstanding Contributions of International Cooperation by the Chinese Medical Doctor Association’s (CMDA) Society for Neuro-Oncology (SNO). The presentation was…...
Yoga for Insomnia, Anxiety and Socializing in Cancer Patients
A discipline consisting of movements through a sequence of postures in coordination with focused breathing, yoga’s documented benefits include increased flexibility, better strength, lowered blood pressure and the reduced severity of insomnia. Many people attribute recovery from depression and anxiety to the regular practice of yoga. Could its practice be…...
Spurring on the Next Generation
The Asian Fund for Cancer Research and the US Chinese Anti-Cancer Association jointly awarded six outstanding Chinese cancer researchers in the early stages of their careers with the 2018 USCACA-AFCR Young Investigator Award. Scholars received a certificate for the Award and a cheque in the amount of U.S. $1,000 in…...
New Faces
The Asian Fund for Cancer Research is pleased and honored to have recently both expanded its board of directors and established a council of advisors. Franck Le Deu, a senior partner in the Hong Kong office of McKinsey & Company, where he leads the consultancy’s pharmaceuticals and medical products practice…...
The Pathfinder
The “Ras/Raf/MEK/ERK pathway” is a mouthful. Oncologists will tell you the same thing. But behind the long phrase is an important field of cancer research—one in which Jiancheng Hu, Ph.D., a scientist supported by the Asian Fund for Cancer Research since 2017, is a renowned expert. Ras is a family…...